Comparidon of the effectiveness of articaine and mepivacaine on lingual anesthesia by infiltration injection

Comparidon of the effectiveness of 4% articaine and 3% mepivacaine on lingual anesthesia by infiltration injection

Status

Recruiting

Phases

Phase 2

Study type

Interventional

Source

IRCT

Registry ID

IRCT20170307032929N4

Enrollment

Registered

2021-02-16

Start date

2021-02-23

Completion date

Unknown

Last updated

2021-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Extraction of anterior teeth of mandibular.

Interventions

Intervention 1: Intervention group:a part of the anterior of the mandible that receives 4% articaine anesthesia with epinephrine 1: 100000 and is produced by the elixir factory by infiltration method

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: People older than 18 years Complete patient consent to participate in the study. Those in whom upper posterior teeth is bilaterally indicated. Indication of PSA block injection on both sides of the maxilla

Exclusion criteria

Exclusion criteria: Systemic and neurological diseases. Allergy to sulfite (allergic asthma) or local anesthetic. Smoking, alcohol, drugs. Any acute infection and swelling

Design outcomes

Primary

Measure	Time frame
Lingual anesthesia. Timepoint: Immediately after infiltration. Method of measurement: After infiltration injection, with decollation of lingual region the pain is recorded in VAS system.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactFina Navi

Islamic Azad University

F_navi@dentaliau.ac.ir+98 21 2256 4571

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026